eTheRNA raised €34M in a Series B round in Jun 2020. The company is based in Jette, Belgium. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €34M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
